ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

REBECCA HOWARD MSN,APN,CNS

2200 W BERRY AVE ARAPAHOE/DOUGLAS MENTAL HEALTH NETWORK

Littleton | Colorado | 80120

(303) 347-6436

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

Clinical Nurse Specialist, Psychiatric/Mental Health

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

4,831Medicare Part D Prescriptions Filled, Including Refills
$877K Total Retail Price of All Prescriptions
235 Patients Receiving at Least One Drug in Part D
18%Patients 65 Years and Older
94% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
BENZTROPINE MESYLATE 305 0 R
OLANZAPINE 276 18
RISPERIDONE 232 0
GABAPENTIN 202 12
ABILIFY 195 0
LAMOTRIGINE 185 0
ZOLPIDEM TARTRATE 160 11
CLOZAPINE 158 0
TOPIRAMATE 149 19
TRAZODONE HCL 146 26
VENLAFAXINE HCL ER 120 11
LITHIUM CARBONATE 119 0
QUETIAPINE FUMARATE 117 0
PROPRANOLOL HCL 117 0
INVEGA SUSTENNA 112 0
CITALOPRAM HBR 104 0
FLUOXETINE HCL 98 13
INVEGA 92 0
OXCARBAZEPINE 86 0
SERTRALINE HCL 84 0
CARBAMAZEPINE 76 0
SAPHRIS 68 0
DIVALPROEX SODIUM ER 67 0
ZIPRASIDONE HCL 67 0
DIVALPROEX SODIUM 66 22
BUSPIRONE HCL 64 0
SEROQUEL 61 0
MIRTAZAPINE 60 12
PAROXETINE HCL 59 0
TRIHEXYPHENIDYL HCL 57 11 R
BUPROPION HCL SR 51 13
HALOPERIDOL 50 0
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 3, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.